Skip to main content

anti-PD-1 therapy

Research in Review
11/14/2016
JCP Editors
An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...
An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...
An...
11/14/2016
Journal of Clinical Pathways